{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:45:49Z","timestamp":1769517949678,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10637-022-01250-6","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T02:02:17Z","timestamp":1651111337000},"page":"718-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Exportin-1 is critical for cell proliferation and survival in adult T cell leukemia"],"prefix":"10.1007","volume":"40","author":[{"given":"Chie","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"1250_CR1","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","volume":"3","author":"M Iwanaga","year":"2012","unstructured":"Iwanaga M, Watanabe T, Yamaguchi K (2012) Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol 3:322","journal-title":"Front Microbiol"},{"key":"1250_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/pathogens9070543","volume":"9","author":"S Mohanty","year":"2020","unstructured":"Mohanty S, Harhaj EW (2020) Mechanisms of oncogenesis by HTLV-1 Tax. Pathogens 9:543","journal-title":"Pathogens"},{"key":"1250_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.13338","volume":"169","author":"T Ishida","year":"2015","unstructured":"Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K, Uike N, Saburi Y, Nosaka K, Utsunomiya A, Tobinai K, Fujiwara H, Ishitsuka K, Yoshida S, Taira N, Moriuchi Y, Imada K, Miyamoto T, Akinaga S, Tomonaga M, Ueda R (2015) Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 169:672\u2013682","journal-title":"Br J Haematol"},{"key":"1250_CR4","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S2352-3026(15)00284-7","volume":"3","author":"M Ogura","year":"2016","unstructured":"Ogura M, Imaizumi Y, Uike N, Asou N, Utsunomiya A, Uchida T, Aoki T, Tsukasaki K, Taguchi J, Choi I, Maruyama D, Nosaka K, Chen N, Midorikawa S, Ohtsu T, Tobinai K (2016) Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study. Lancet Haematol 3:e107\u2013e118","journal-title":"Lancet Haematol"},{"key":"1250_CR5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3389\/fmicb.2020.01207","volume":"11","author":"K Tsukasaki","year":"2020","unstructured":"Tsukasaki K, Mar\u00e7ais A, Nasr R, Kato K, Fukuda T, Hermine O, Bazarbachi A (2020) Diagnostic approaches and established treatments for adult T cell leukemia lymphoma. Front Microbiol 11:1207","journal-title":"Front Microbiol"},{"key":"1250_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1182\/blood.2019004045","volume":"137","author":"LB Cook","year":"2021","unstructured":"Cook LB, Phillips AA (2021) How I treat adult T-cell leukemia\/lymphoma. Blood 137:459\u2013470","journal-title":"Blood"},{"key":"1250_CR7","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1038\/s41375-020-0958-y","volume":"34","author":"B Nachmias","year":"2020","unstructured":"Nachmias B, Schimmer AD (2020) Targeting nuclear import and export in hematological malignancies. Leukemia 34:2875\u20132886","journal-title":"Leukemia"},{"key":"1250_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10637-020-01007-z","volume":"39","author":"C Ishikawa","year":"2021","unstructured":"Ishikawa C, Senba M, Mori N (2021) Importin \u03b21 regulates cell growth and survival during adult T cell leukemia\/lymphoma therapy. Invest New Drugs 39:317\u2013329","journal-title":"Invest New Drugs"},{"key":"1250_CR9","doi-asserted-by":"publisher","first-page":"15534","DOI":"10.1021\/acs.jmedchem.1c01145","volume":"64","author":"S Liu","year":"2021","unstructured":"Liu S, Qiao W, Sun Q, Luo Y (2021) Chromosome region maintenance 1 (XPO1\/CRM1) as an anticancer target and discovery of its inhibitor. J Med Chem 64:15534\u201315548","journal-title":"J Med Chem"},{"key":"1250_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/294770a0","volume":"294","author":"I Miyoshi","year":"1981","unstructured":"Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y (1981) Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294:770\u2013771","journal-title":"Nature"},{"key":"1250_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1126\/science.6980467","volume":"217","author":"N Yamamoto","year":"1982","unstructured":"Yamamoto N, Okada M, Koyanagi Y, Kannagi M, Hinuma Y (1982) Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science 217:737\u2013739","journal-title":"Science"},{"key":"1250_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1182\/blood.V64.2.482.482","volume":"64","author":"HP Koeffler","year":"1984","unstructured":"Koeffler HP, Chen IS, Golde DW (1984) Characterization of a novel HTLV-infected cell line. Blood 64:482\u2013490","journal-title":"Blood"},{"key":"1250_CR13","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415\u20137419","journal-title":"Proc Natl Acad Sci USA"},{"key":"1250_CR14","first-page":"155","volume":"71","author":"I Miyoshi","year":"1980","unstructured":"Miyoshi I, Kubonishi I, Sumida M, Hiraki S, Tsubota T, Kimura I, Miyamoto K, Sato J (1980) A novel T-cell line derived from adult T-cell leukemia. Gan 71:155\u2013156","journal-title":"Gan"},{"key":"1250_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ijc.2910340213","volume":"34","author":"K Sugamura","year":"1984","unstructured":"Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M, Hinuma Y (1984) Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer 34:221\u2013228","journal-title":"Int J Cancer"},{"key":"1250_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1349-7006.1990.tb02554.x","volume":"81","author":"Y Tanaka","year":"1990","unstructured":"Tanaka Y, Yoshida A, Takayama Y, Tsujimoto H, Tsujimoto A, Hayami M, Tozawa H (1990) Heterogeneity of antigen molecules recognized by anti-tax1 monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retroviruses. Jpn J Cancer Res 81:225\u2013231","journal-title":"Jpn J Cancer Res"},{"key":"1250_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbagrm.2014.03.013","volume":"1849","author":"G Bretones","year":"2015","unstructured":"Bretones G, Delgado MD, Le\u00f3n J (2015) Myc and cell cycle control. Biochim Biophys Acta 1849:506\u2013516","journal-title":"Biochim Biophys Acta"},{"key":"1250_CR18","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/sj.bjc.6605039","volume":"100","author":"RP Sahu","year":"2009","unstructured":"Sahu RP, Batra S, Srivastava SK (2009) Activation of ATM\/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer 100:1425\u20131433","journal-title":"Br J Cancer"},{"key":"1250_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094298","volume":"9","author":"NM Fofaria","year":"2014","unstructured":"Fofaria NM, Kim SH, Srivastava SK (2014) Piperine causes G1 phase cell cycle arrest and apoptosis in melanoma cells through checkpoint kinase-1 activation. PLoS ONE 9:e94298","journal-title":"PLoS ONE"},{"key":"1250_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026070","volume":"6","author":"AB Williams","year":"2016","unstructured":"Williams AB, Schumacher B (2016) p53 in the DNA-damage-repair process. Cold Spring Harb Perspect Med 6:a026070","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1250_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/leu.2013.115","volume":"28","author":"YT Tai","year":"2014","unstructured":"Tai YT, Landesman Y, Acharya C, Calle Y, Zhong MY, Cea M, Tannenbaum D, Cagnetta A, Reagan M, Munshi AA, Senapedis W, Saint-Martin JR, Kashyap T, Shacham S, Kauffman M, Gu Y, Wu L, Ghobrial I, Zhan F, Kung AL, Schey SA, Richardson P, Munshi NC, Anderson KC (2014) CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications. Leukemia 28:155\u2013165","journal-title":"Leukemia"},{"key":"1250_CR22","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.18632\/oncotarget.2174","volume":"5","author":"J Mendonca","year":"2014","unstructured":"Mendonca J, Sharma A, Kim HS, Hammers H, Meeker A, De Marzo A, Carducci M, Kauffman M, Shacham S, Kachhap S (2014) Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer. Oncotarget 5:6102\u20136112","journal-title":"Oncotarget"},{"key":"1250_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/cdd.2017.169","volume":"25","author":"BJ Aubrey","year":"2018","unstructured":"Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A (2018) How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ 25:104\u2013113","journal-title":"Cell Death Differ"},{"key":"1250_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10495-008-0208-7","volume":"13","author":"JM Taylor","year":"2008","unstructured":"Taylor JM, Nicot C (2008) HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis 13:733\u2013747","journal-title":"Apoptosis"},{"key":"1250_CR25","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1038\/sj.onc.1208978","volume":"24","author":"R Grassmann","year":"2005","unstructured":"Grassmann R, Aboud M, Jeang KT (2005) Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24:5976\u20135985","journal-title":"Oncogene"},{"key":"1250_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","volume":"30","author":"P Viatour","year":"2005","unstructured":"Viatour P, Merville M-P, Bours V, Chariot A (2005) Phosphorylation of NF-\u03baB and I\u03baB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43\u201352","journal-title":"Trends Biochem Sci"},{"key":"1250_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41571-020-00442-4","volume":"18","author":"AS Azmi","year":"2021","unstructured":"Azmi AS, Uddin MH, Mohammad RM (2021) The nuclear export protein XPO1 \u2013 from biology to targeted therapy. Nat Rev Clin Oncol 18:152\u2013169","journal-title":"Nat Rev Clin Oncol"},{"key":"1250_CR28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/emboj\/17.2.554","volume":"17","author":"J Roth","year":"1998","unstructured":"Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ (1998) Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J 17:554\u2013564","journal-title":"EMBO J"},{"key":"1250_CR29","doi-asserted-by":"publisher","first-page":"7288","DOI":"10.1128\/MCB.18.12.7288","volume":"18","author":"DA Freedman","year":"1998","unstructured":"Freedman DA, Levine AJ (1998) Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol Cell Biol 18:7288\u20137293","journal-title":"Mol Cell Biol"},{"key":"1250_CR30","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1182\/blood-2013-04-495374","volume":"122","author":"CJ Walker","year":"2013","unstructured":"Walker CJ, Oaks JJ, Santhanam R, Neviani P, Harb JG, Ferenchak G, Ellis JJ, Landesman Y, Eisfeld AK, Gabrail NY, Smith CL, Caligiuri MA, Hokland P, Roy DC, Reid A, Milojkovic D, Goldman JM, Apperley J, Garzon R, Marcucci G, Shacham S, Kauffman MG, Perrotti D (2013) Preclinical and clinical efficacy of XPO1\/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias. Blood 122:3034\u20133044","journal-title":"Blood"},{"key":"1250_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0968-0004(99)01375-4","volume":"24","author":"TA Millward","year":"1999","unstructured":"Millward TA, Zolnierowicz S, Hemmings BA (1999) Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 24:186\u2013191","journal-title":"Trends Biochem Sci"},{"key":"1250_CR32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/ajh.24451","volume":"91","author":"F Jardin","year":"2016","unstructured":"Jardin F, Pujals A, Pelletier L, Bohers E, Camus V, Mareschal S, Dubois S, Sola B, Ochmann M, Lemonnier F, Viailly PJ, Bertrand P, Maingonnat C, Traverse-Glehen A, Gaulard P, Damotte D, Delarue R, Haioun C, Argueta C, Landesman Y, Salles G, Jais JP, Figeac M, Copie-Bergman C, Molina TJ, Picquenot JM, Cornic M, Fest T, Milpied N, Lemasle E, Stamatoullas A, Moeller P, Dyer MJ, Sundstrom C, Bastard C, Tilly H, Leroy K (2016) Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma. Am J Hematol 91:923\u2013930","journal-title":"Am J Hematol"},{"key":"1250_CR33","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, Totoki Y, Chiba K, Sato-Otsubo A, Nagae G, Ishii R, Muto S, Kotani S, Watatani Y, Takeda J, Sanada M, Tanaka H, Suzuki H, Sato Y, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Iwanaga M, Ma G, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Ogasawara H, Sato T, Sasai K, Muramoto K, Penova M, Kawaguchi T, Nakamura H, Hama N, Shide K, Kubuki Y, Hidaka T, Kameda T, Nakamaki T, Ishiyama K, Miyawaki S, Yoon SS, Tobinai K, Miyazaki Y, Takaori-Kondo A, Matsuda F, Takeuchi K, Nureki O, Aburatani H, Watanabe T, Shibata T, Matsuoka M, Miyano S, Shimoda K, Ogawa S (2015) Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet 47:1304\u20131315","journal-title":"Nat Genet"},{"key":"1250_CR34","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1182\/blood-2017-08-797886","volume":"131","author":"C Chen","year":"2018","unstructured":"Chen C, Siegel D, Gutierrez M, Jacoby M, Hofmeister CC, Gabrail N, Baz R, Mau-Sorensen M, Berdeja JG, Savona M, Savoie L, Trudel S, Areethamsirikul N, Unger TJ, Rashal T, Hanke T, Kauffman M, Shacham S, Reece D (2018) Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia. Blood 131:855\u2013863","journal-title":"Blood"},{"key":"1250_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137210","volume":"10","author":"Y Tabe","year":"2015","unstructured":"Tabe Y, Kojima K, Yamamoto S, Sekihara K, Matsushita H, Davis RE, Wang Z, Ma W, Ishizawa J, Kazuno S, Kauffman M, Shacham S, Fujimura T, Ueno T, Miida T, Andreeff M (2015) Ribosomal biogenesis and translational flux inhibition by the selective inhibitor of nuclear export (SINE) XPO1 antagonist KPT-185. PLoS ONE 10:e0137210","journal-title":"PLoS ONE"},{"key":"1250_CR36","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1038\/onc.2008.312","volume":"27","author":"B Hoffman","year":"2008","unstructured":"Hoffman B, Liebermann DA (2008) Apoptotic signaling by c-MYC. Oncogene 27:6462\u20136472","journal-title":"Oncogene"},{"key":"1250_CR37","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.1038\/srep12841","volume":"5","author":"T Ichikawa","year":"2015","unstructured":"Ichikawa T, Nakahata S, Fujii M, Iha H, Morishita K (2015) Loss of NDRG2 enhanced activation of the NF-\u03baB pathway by PTEN and NIK phosphorylation for ATL and other cancer development. Sci Rep 5:12841","journal-title":"Sci Rep"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-022-01250-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-022-01250-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-022-01250-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:47:03Z","timestamp":1678510023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-022-01250-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1250"],"URL":"https:\/\/doi.org\/10.1007\/s10637-022-01250-6","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors consent to the publication of this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"No competing interests or conflict of interest is reported by the authors.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}